---
doc_id: CYCLE-0-FIRST-CYCLE-REPORT
status: PROPOSAL
owner: UNASSIGNED — VALIDATION REQUIRED
source: INTENSICARE_V2_ORCHESTRATOR_PROMPT.md §17, §21; all cycle-0 artifacts under docs/
date_collected: 2026-08-15
collector: delivery orchestrator
last_updated: 2026-08-15
---

# Cycle 0 — First Execution Cycle Report (SPARK bootstrap)

This is the orchestrator's report required by prompt §21, covering the first
safe execution cycle. Evidence labels per `docs/00-governance/evidence-notation.md`.

## 1. Repository and access state (OBSERVED, 2026-08-14)

- V2 repository: `https://github.com/Omni-Saude/intensicare-V2`, independent history
  (initial commit `cb35521`), work on branch `cycle-0/spark-foundation`.
- Legacy repository present read-only at `https://github.com/Omni-Saude/intensicare`,
  never modified. Provenance defect recorded: `INTENSICARE_TECHNICAL_ASSESSMENT.md`
  is an **untracked working-tree file** — not commit-pinned; line citations can
  drift silently (see pathway-portfolio handoff; EVID register).
- AMH repository `Omni-Saude/amh-data-platform` (private): pinned execution
  commit `0a07a6f1fab36fb2f5eeee0fcd8e945c95f67116` — OBSERVED identical to
  `main` HEAD at pin time (**no drift** between the prompt's evidence snapshot
  and the execution commit). Maezo manifest producer commit
  `09a0a282e69f49aa9c6944b25afb35eee65fcc9c` independently verified to exist.
- Access: `gh` CLI OAuth on account `rodaquino-OMNI` (scopes gist/read:org/repo/workflow),
  read-only use only, no credentials recorded anywhere. DISCREPANCY (ASM-0001,
  BLK-0009): the prompt describes a **GitHub App installation**; what was
  observed is an OAuth token on the same account. Revalidation of the App
  installation is a G0 blocker.
- AMH repo license: GitHub reports `NOASSERTION` → license/IP authority
  unestablished (BLK-0010).

## 2. Documentary evidence vs unverified claims

- All 15 evidence constraints in prompt §2 were re-verified file-by-file at the
  pinned commit: **15/15 hold** (12 CONFIRMED-AT-COMMIT, 2 confirmed with
  nuance, 1 internal DIFFERS — Maezo manifest self-declares PUBLISHED while the
  README calls it UNPUBLISHED). See `docs/08-interoperability/amh-data/claim-verification-matrix.md`.
- Four-layer discipline enforced: Layer 1 (declared contract) substantially
  established; **Layers 2 (deployed) and 4 (operational) have zero evidence**
  (no environment access); Layer 3 (populated) has only SOURCE claims. AMH's
  own population figures are never treated as OBSERVED.
- Material new findings beyond the prompt's snapshot (all OBSERVED at pinned commit):
  1. Vital-sign exclusion is **structural** — the only Observation profile
     pattern-fixes `category: laboratory`; a conformant vital-sign instance is
     impossible without a new AMH profile.
  2. The documented Observation unblocking plan (free-text `valueString`)
     **violates the profile's own LOINC/UCUM bindings** — "unblocked" may not
     mean rule-consumable (contradiction C-4).
  3. The authentication contradiction is **three-way** (CapabilityStatement
     SMART vs HAPI README mTLS vs an implemented but not-demonstrably-deployed
     JWT authorizer).
  4. The identity conflict is **six-way**, not four-way (ADR-043 cross-PJ
     index and ADR-042/AMH-020b portable-subject-reference design, neither in
     force). The live batch producer emits **zero FHIR extensions** while
     profiles mandate `mpiId`/`tenantId` extensions 1..1; consent logic is
     absent from the live channel; CPF flows in clear.

## 3. Blockers and decisions requiring human owners

Eleven G0 blockers are open (`docs/00-governance/registers/blockers-register.md`):
eight unnamed decision-owner roles (product, clinical safety, security,
privacy/legal, data-platform, UX, operations, intended-use approver), GitHub
App revalidation, AMH license/IP authority, and branch protection (repo-admin
action; requested settings in `docs/14-devsecops-and-delivery/branch-protection-request.md`).
Gate G0 is **NOT CLOSED**. Gate G1 is **NOT satisfied** (42 blocking
validation items, `docs/02-users-and-workflows/g1-validation-backlog.md`).
Six identity adjudication questions (AQ-1..AQ-6) await AMH owners
(`docs/08-interoperability/amh-data/identity-adjudication/`).

Per prompt §20, this cycle **stopped at the human gates rather than fabricate
approval**: no owner was named, nothing was marked DECIDED, no ADR left
`proposed`.

## 4. Compatibility finding (hypothesis, not decision)

**Integration candidate; not currently demonstrated compatible for actionable
ICU evaluation** — re-verified and strengthened. Hard portfolio constraint:
laboratory Observation blocked at a measured-zero source; no vital-sign
profile/feed exists structurally. Gate G3's production-like condition is
currently unsatisfiable by anyone (AMH has only `dev` provisioned). Six of
eight unblocking conditions run through AMH owners, not V2 engineering.

## 5. Pathway portfolio state (honest count)

9 candidates inventoried from legacy evidence (the assessment enumerates only
4 scores + 1 stub; the "12 pathways / 959 rules" exist only as counts —
recorded, not fabricated). Hard-gate result: **0 PASS / 88 FAIL / 11 UNKNOWN**;
**actionable-pathway count today: zero**. No gate was weakened. Classifications:
3 RESEARCH, 5 DEFER (binding constraint is AMH-side), 1 REJECT.
Portfolio-selection method (MCDA) is specified but execution is BLOCKED on
ratified weights and owners. See `docs/05-clinical-safety/pathway-portfolio/`.

## 6. Safety and security state

- Hazard log: **44 hazards** (all OPEN, PROPOSAL), 41 safety requirements,
  safety-case skeleton with evidence slots honestly EMPTY/PARTIAL.
- HAZ-0043 (S4/L4, "Unacceptable" band): permanent `not_evaluated` from
  structurally empty sources habituating into reassuring quiet — the one
  hazard whose enabling condition is **already true today**.
- Threat model: 67 threats across 12 trust boundaries, 50 candidate controls,
  27 P0 / 39 P1 triage (no acceptance), THR↔HAZ bidirectionally linked;
  supply-chain hazard gap G-1 closed by linkage. G6: 4/4 conditions unmet;
  cheapest high-value action today is **branch protection**.
- Privacy map skeleton exists; all legal determinations VALIDATION REQUIRED.

## 7. What was built (evidence, not activity)

59 artifacts, ~70k lines, all evidence-labeled with provenance front-matter,
enforced by two blocking CI gates (`.github/workflows/docs-gates.yml`,
`scripts/check_doc_conventions.py`, `scripts/check_forbidden_content.py`) —
both **exit 0** on the full tree at report time. Docs map per prompt §16:
governance + registers (00), intended use (01), users/workflows (02), domain
model + invariants (03), clinical safety + pathway portfolio (05),
architecture + ADR program (06: template, 24-ADR index, ADR-0001/0002
`proposed`), AMH dossier + identity adjudication (08), security/privacy/threat
model (11), test architecture (12), DevSecOps policy (14), this report (15).

## 8. Specialist roster used (prompt §4 compliance)

Eleven narrow specialists executed with §4 task packets, disjoint write
scopes, and handoff reports; independence pairs respected (no specialist
self-approved; hazard owner adjudicated the threat modeler's proposals;
CI engineer reported violations in another specialist's files rather than
weakening the gate). Model routing: deep clinical/compatibility/architecture
analysis on a high-reasoning tier; structured scaffolding on a mid tier.

## 9. Deliberately not implemented in this cycle

No application code, no stack/technology selection (24 ADRs pending, all
`proposed`/`not-started`), no pathway selection, no AMH transport choice, no
contract acceptance, no environment/infrastructure, no clinical claims, no
compliance claims, no user-facing UX design (research must precede design per
G1), no MCP surface. Per prompt §21 the first response proposes no final stack.

## 10. Next critical-path tasks (dependency order)

1. **Human act (G0)**: name the eight decision owners; grant intended-use
   approver; resolve GitHub App revalidation; establish AMH license/IP
   authority; configure branch protection (BLK-0001..0011).
2. **AMH owners**: answer AQ-1..AQ-6 (identity), the 10 open contract
   questions, and contradictions C-1..C-4.
3. **G1**: commission the contextual-inquiry plan
   (`docs/02-users-and-workflows/user-research-plan.md`) — including the
   pre-deployment baselines that expire at go-live (G2-VAL-0025, VAL-0035).
4. **Then**: ADR-0001 boundary decision cycle, AMH×IntensiCare contract
   manifest negotiation, and the G7 vertical slice — in that order.
